Finch Therapeutics Group, Inc. (FNCH)
OTCMKTS: FNCH · Delayed Price · USD
1.370
+0.150 (12.30%)
Jul 2, 2024, 2:44 PM EDT - Market closed
Finch Therapeutics Group Market Cap
Finch Therapeutics Group has a market cap or net worth of $2.20 million as of July 2, 2024. Its market cap has decreased by -85.71% in one year.
Market Cap
2.20M
Enterprise Value
11.00M
1-Year Change
-85.71%
Ranking
n/a
Category
Stock Price
$1.37
Market Cap Chart
Since the IPO on March 19, 2021, Finch Therapeutics Group's market cap has decreased from $801.47M to $2.20M, a decrease of -99.73%. That is a compound annual growth rate of -84.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 24, 2024 | 2.90M | -50.00% |
| Dec 29, 2023 | 5.80M | -74.78% |
| Dec 30, 2022 | 23.00M | -95.14% |
| Dec 31, 2021 | 473.40M | -40.93% |
| Mar 19, 2021 | 801.47M | - |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 869.02B |
| Novo Nordisk | 643.34B |
| UnitedHealth Group | 455.27B |
| Johnson & Johnson | 352.43B |
| Merck & Co. | 323.95B |
| AbbVie | 300.85B |
| AstraZeneca | 241.65B |
| Novartis AG | 208.44B |